A High-Dose Cortisol Receptor Antagonist for the Management of Severe Hyperglycemia in a Patient With an Adrenocortical Carcinoma
Division
North Florida
Hospital
Osceola Regional Medical Center
Document Type
Abstract
Publication Date
5-3-2021
Keywords
hyperglycemia, adrenocortical carcinoma
Disciplines
Endocrine System Diseases | Internal Medicine | Neoplasms
Publisher or Conference
Journal of the Endocrine Society
Recommended Citation
Merino H, Luna NT, Paniagua GZ, Yau H. A High-Dose Cortisol Receptor Antagonist for the Management of Severe Hyperglycemia in a Patient With an Adrenocortical Carcinoma. J Endocr Soc. 2021;5(Suppl 1):A103-A104. Published 2021 May 3. doi:10.1210/jendso/bvab048.207
COinS
Comments
Abstract published in the Journal of the Endocrine Society's abstract supplement.